SMA drug Zolgensma finally makes Alberta's Rare Diseases Drug Coverage Program
Coverage for Zolgensma, a gene therapy used to treat spinal muscular atrophy, is now permanently available in Alberta.
The therapy was added to the province's Rare Diseases Drug Coverage Program after the pan-Canadian Pharmaceutical Alliance (pCPA) reached a long-term pricing agreement with manufacturer Novartis Pharmaceuticals Canada Inc. in October.
Alberta Health Minister Jason Copping said in a statement the government was "extremely pleased" at the development and Alberta's new ability to offer the treatment on a more secure basis.
The province had been providing access to the drug on its own pending a national drug review, approval and the price negotiations with Novartis.
Zolgensma, a one-time treatment with a price tag of $2.91 million, is administered by intravenous infusion to replace a missing or faulty gene that results in spinal muscular atrophy (SMA). The rare disorder can cause a loss of muscle function and is seen in about one in 10,000 Canadian babies each year, according to the National Organization for Rare Disorders.
Zolgensma is supposed to stop the disease's progression and restore protein production of the missing or defective SMN1 gene. It must be administered when a patient is a toddler.
Several Alberta families led the push to have it approved and covered in Alberta and Canada.
Spinraza, a spinal injection given three times a year that can be used as a treatment for SMA, is also covered under the Alberta Drug Benefit List.
CTVNews.ca Top Stories
Quebec nurse had to clean up after husband's death in Montreal hospital
On a night she should have been mourning, a nurse from Quebec's Laurentians region says she was forced to clean up her husband after he died at a hospital in Montreal.
Northern Ont. lawyer who abandoned clients in child protection cases disbarred
A North Bay, Ont., lawyer who abandoned 15 clients – many of them child protection cases – has lost his licence to practise law.
Bank of Canada officials split on when to start cutting interest rates
Members of the Bank of Canada's governing council were split on how long the central bank should wait before it starts cutting interest rates when they met earlier this month.
Maple Leafs fall to Bruins in Game 3, trail series 2-1
Brad Marchand scored twice, including the winner in the third period, and added an assist as the Boston Bruins downed the Toronto Maple Leafs 4-2 to take a 2-1 lead in their first-round playoff series Wednesday
Cuban government apologizes to Montreal-area family after delivering wrong body
Cuba's foreign affairs minister has apologized to a Montreal-area family after they were sent the wrong body following the death of a loved one.
'It was instant karma': Viral video captures failed theft attempt in Nanaimo, B.C.
Mounties in Nanaimo, B.C., say two late-night revellers are lucky their allegedly drunken antics weren't reported to police after security cameras captured the men trying to steal a heavy sign from a downtown business.
What is changing about Canada's capital gains tax and how does it impact me?
The federal government's proposed change to capital gains taxation is expected to increase taxes on investments and mainly affect wealthy Canadians and businesses. Here's what you need to know about the move.
New Indigenous loan guarantee program a 'really big deal,' Freeland says at Toronto conference
Canada's Deputy Prime Minister Chrystia Freeland was among the 1,700 delegates attending the two-day First Nations Major Projects Coalition (FNMPC) conference that concluded Tuesday in Toronto.
'Life was not fair to him': Daughter of N.B. man exonerated of murder remembers him as a kind soul
The daughter of a New Brunswick man recently exonerated from murder, is remembering her father as somebody who, despite a wrongful conviction, never became bitter or angry.